Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000117919 | SCV000312440 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000268910 | SCV000435357 | likely benign | Early Infantile Epileptic Encephalopathy, Autosomal Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312211 | SCV000846097 | benign | Inborn genetic diseases | 2016-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001514554 | SCV001722426 | benign | Developmental and epileptic encephalopathy, 12 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001598624 | SCV001827258 | benign | not provided | 2020-11-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000117919 | SCV000152195 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |